Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic and pharmacogenomic biomarkers of Parkinson's disease.

Current drug metabolism - 1 Feb 2014

Alonso-Navarro Hortensia, Jimenez-Jimenez Felix Javier, Garcia-Martin Elena, Agundez Jose A G

Abstract excerpt

The relative role of genetic and environmental factors in the pathogenesis of Parkinson's disease (PD) has been the matter of investigation and debate, especially in the last 30 years. The possible interaction between genetic and environmental factors led to a great number of association studies between single nucleotide polymorphisms (SNPs) of many candidate genes and PD risk. In this study we summarized and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Environmental Exposure
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome-Wide Association Study

Share to Genomics

Share to Parkinson Disease

Share to Pharmacogenetics

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 24694231
DOI: 10.2174/138920021502140327175404

Genes

HFE
ABCB1
BDNF
CAT
COMT
DBH
DDC
GSTM1
GSTM3
GSTO1
GSTP1
HNMT
KEAP1
MAPT
MTHFR
MTR
NAT2
PON1
PON2
SNCA
TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic and pharmacogenomic biomarkers of Parkinson's disease.PMID 24694231Read ↗

Gene-environment interactions in parkinsonism and Parkinson's disease: the Geoparkinson study.Semantic proximity Read ↗

Advances in understanding genomic markers and pharmacogenetics of Parkinson's disease.Semantic proximity Read ↗

Polymorphism of neurodegeneration-related genes associated with Parkinson's disease risk.Semantic proximity Read ↗

Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson’s diseaseSemantic proximity Read ↗

Cytochrome P450 2E1 gene polymorphisms/haplotypes and Parkinson's disease in a Swedish population.Semantic proximity Read ↗

Leads from xenobiotic metabolism genes for Parkinson's disease among north Indians.Semantic proximity Read ↗

Epidemiology and etiology of Parkinson's disease: a review of the evidence.Semantic proximity Read ↗

Anti-Parkinson's disease drugs and pharmacogenetic considerationsSemantic proximity Read ↗

Parkinson’s Disease: Biomarkers, Treatment, and Risk FactorsSemantic proximity Read ↗

Environmental-Genetic Interactions in the Pathogenesis of Parkinson's DiseaseSemantic proximity Read ↗

Polymorphism in environment responsive genes and association with Parkinson disease.Semantic proximity Read ↗

Association of A313 G polymorphism (GSTP1*B) in the glutathione-S-transferase P1 gene with sporadic Parkinson's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.